On behalf of allied academies conferences, it is my pleasure to invite all of the noble laureates, Great scientists, young researchers,academicians, business delegates and all the students from all over the world
Allied Academies cordially welcomes all the attendees, speakers, sponsor’s and other research expertise from all over the world to the “Pharma Congress”. We are very much honored to invite you all to exchange and share your skill and experience about Pharmaceutical technologies, recent trends and many more.This seminar will float with a theme:‘Frontier Novelties in Pharmaceutical Industry & Drug Delivery Technology’.
It is a great
honour to welcome you and participatein the pharmaceutical and novel drug
delivery conferenceLet us have a
great meet in the wonderful city of Tokyo in Japan.
Session 1:- Drug Formulation
The practice of drug delivery has changed in the past few decades and greater changes are anticipated in the near future. For the target of amplifying information on the present researchers on developing drug delivery systems via novel techniques for Pharmaceutical formulation development, this session is centered around quality topics like, Drug Delivery design, versatile polymer in drug delivery and Controlled Drug Delivery, Drug interactions, improvement of pharmaceutical product, Sustained Drug Delivery Systems, may be an unambiguous architecture session that plays a vital role in the fields of drug formulation and development.
- Novel Drug Delivery Systems.
- Routes of Drug Administration
- Nucleic Acid Based Drug Delivery
- Bio therapeutics as Novel Technique in Drug Delivery
Session 2:- Pharmacokinetics
It gives a knowledge to the current researcher on various parameters i.e. absorption, distribution and elimination of a drug, this session themed quality topics on Bio analytical methods, Mass Spectrometry, Clinical Pharmacokinetics are a uniquely architect session to play an important role in the fields of Drug discovery and formulation. Knowledge of pharmacokinetic principles helps prescribers alter dose additional accurately and rapidly.
Session 3:- Pharmaceutical NanotechnologyPharmaceutical Nanotechnology emerging new technologies for developing customized solutions for drug delivery systems. The system positively impacts on the rate of absorption, distribution, metabolism, and excretion of the drug or other related chemical substances in the body. In addition the drug binds to its target receptor and influences that receptor’s signalling and activity. Pharmaceutical nanotechnology embraces applications of Nano science to pharmacy as nanomaterial and as devices like drug delivery, diagnostic, imaging and biosensor.
- Regulatory requirements for pharmaceutical
- Pharmaceutical Supply Chain Optimization
Session 4:- PharmacodynamicsThe session talks about the molecular effect of drugs on the body and involves receptor binding, post receptor effects and chemical interactions. The keynote of this session is to explain about the relationship between dose and response (drug effects). The ultimate goal is to study on maintaining the particular drug concentration within the proper therapeutic rate there by avoiding toxicity while providing an adequate concentration of the drug to provide the desired effect.
- Empirical Pharmacodynamics Models
- Other Pharmacodynamics Models
- Unification of Pharmacodynamics Models
- Nonlinear Concepts in Pharmacodynamics
- Pharmacodynamics Application
Session 5:- Drug delivery technologiesThese mainly enhances on efficacy of a drug adsorption and patient experience taste makers increase the commercial viability of your pharmaceutical products by neutralizing the strong, bitter tastes of certain oral medical formulations. Bioavailability of medications within the system can be achieved by increasing the dissolution rate with specialized drug delivery enhancement products. Enhancing the drug delivery technology of your final pharmaceutical formulation can increase its commercial success.
Session 6:- Green sustainable pharmaGreen pharmacy is a new approach where it is about the environment, social and economic aspects, that which deals with the environment issues on the pharmaceutical entity that deals with the resources and waste issues for example during the synthesis of a product there would be several compounds which cannot degrade and causes harm to the environment to reduce such risk aspects are to be analysed. Another issue is the people using pharmaceuticals such as pharmacists, medical doctors and patients. How can they contribute to more efficient use of pharmaceuticals with less environmental burden and less risk for drinking water?
Session 7:- Control of quality of analytical methodsAnalytical quality control refers to all those processes and procedures designed to ensure that the results of laboratory analysis are consistent, comparable, accurate and within specified limits of precision. Qualitative analysis refers to the measurement of the concentration of the element or compound in a matrix that differs from the element or compound
- Analytical Methods and Control Strategies
- Analytical Method Development and Validation
Session 8:- Pharmaceutical ChemistryPharmaceutical chemistry encompasses drug design, drug synthesis, and the evaluation of drug efficacy and drug safety. Drug discovery is the core of pharmaceutical chemistry.
- Design of safer chemicals and products
- Process Chemistry Considerations
- Structure-activity relationships of drug Moiety
- Synthetic chemistry including combinatorial methods
- Invivo and in vitro bio transformation of drugs
- Modelling and designing of small compounds
- Physico chemical and biological factors that contribute to drug action
- Medicinal Radio compounds or Radiopharmaceuticals
- Global Pharmaceutical Policy
- Impurities and Impurity Profile Significance in API
Session 9:- Pharmacognosy and PhytochemistryThe branch of science that deals with the medicinal drugs obtained from natural origin which states the physical chemical biochemical and biological characteristics of a drug from natural sources where phytochemistry deals with the chemicals that are derived from plants then they are identified, purified, biosynthesized and are used as biologically active compounds in traditional medicines
Session 10:- PharmacogenomicsThe session speaks about the genetic makeup of an individual in response to a therapeutic drug Pharmacogenomics combines pharmacology and genomics to develop effective, safe medications and doses that will be tailored to a person’s genetic ability. Pharmacogenomics use is currently quite limited, but new approaches are under study in clinical trials. It aims to optimize patient management by synthesizing drugs and customizing based on genetic variations in drug response.
Session 11:- vaccine drug delivery systemsImmunization failure due to primary dose or booster dose as patients neglect the latter as vaccine delivery system on the other hand allow for the incorporation of doses of antigens so that booster doses are no longer necessary, as antigens are released slowly and they present to the immune system there by promoting their targeting straight to the immune cells.
- Clinical trials
- Cancer vaccines
- Human vaccines
- HIV/AIDS vaccines
- HPV vaccines
- Therapeutic vaccination for auto immune diseases
- Veterinary vaccines
Session 12:- Combinatorialchemistry in drug discoveryCombinatorial chemistry used to possibly build up a portion of the non-organic subordinates is in itself on a very basic level in light of the normally happening forms; just these procedures are efficiently used to make new leads in drug discovery. Through the quickly developing innovation of combinatorial chemistry, it is currently conceivable to create compound libraries to screen for novel bioactivities. This new, intense innovation has started to help pharmaceutical organizations to discover new drug hopefuls quickly, sparing huge expenses in preclinical improvement, at last changing their crucial way to deal with drug discovery.
Session 13:- Innovative Drug Discovery and NanotechnologyNanotechnology includes creation and use of materials, gadgets or frameworks on the nanometre scale. The innovation is required to make developments and assume a basic part in different biomedical applications, in drug delivery, as well as in atomic imaging, biomarkers and biosensors. Target-specific drug therapy and strategies for early finding of pathologies are the need look into territories where nanotechnology would assume a crucial part
Session 14:- Proteomics in Drug DiscoveryProteomics faces interdisciplinary challenges including biology, chemistry bioinformatics, emerging technologies include two dimensional gel electrophoresis, mass spectrometry, protein arrays, two hybrid systems, isotope encoding, information technologies and activity based assays. These technologies are advancing the utility of proteomics in the drug discovery process
Session 15:- ToxicologyThe session talks about the toxic effect of a drug when it is accumulated too much than the rate. The toxic effects of a drug are dose-dependent and can affect an entire system as in the CNS or a specific organ such as the liver. Drug toxicity usually occurs at doses that exceed the therapeutic efficacy of a drug; however, toxic and therapeutic effects can occur simultaneously.
- Analytical Toxicology
Session 16:- Digital PharmaIt is a believe to some of the people that digital pharma are not only critical to pharmaceutical companies where they bring out novel drugs but to increasing the pharmaceutical industry’s contribution to health care by enabling it to provide innovative services to the patients outcomes thus increases the precised value of Pharma within the health care system where the industry is striving to respond to the needs of health care professionals, patients and payers.
Abstract Submission and Registration
Allied Academies, the largest Open Access Publisherand Scientific Events Organizer, publishing more than 400 Open Access journalsand organizing more than 300 scientific events per year offers membership tostudents. International conference on Pharmaceutics and Novel Drug DeliverySystems Committee would like to invite speakers to submit their research forinclusion in the Pharma Congress 2018 scientific program.
Abstract Submission Details:
We warmly invite you to submit your abstract andattend the International conference on Pharmaceutics and Novel Drug DeliverySystems. Submit your abstract online at Speaker abstract(or) email@example.com
Come Let’s Bring a Transformation in the Scientific Society!!
The Young Researchers Forum offers young researchers the possibility to meet and discuss research topics and methodologies, share and develop ideas, learn from each other and gain knowledge from senior researchers.
Young Researcher Sessions are organized at the Pharmaceutics and Novel Drug Delivery Systems, to provide a unique platform for Young Researchers/Investigators for presenting latest research projects with an in-depth analysis. Allied Academies cordially invites Young Researchers from Universities/Institutes/Industries to present a short oral presentation during the forum. These oral presentations should be of 10 minutes duration in related scientific track followed by 5 minutes question hour. Therefore, presenters are encouraged to give comprehensive and dynamic talks. Applications will be selected based on past research productivity and future promise.
Register Here: http://pharmacongress.alliedacademies.com/registration
Globalized growth of Pharmaceutical industry
According to SESRIC (2011) the global pharmaceutical industry has proved a rapid growth over the years and emerged as one of the fastest growing industries in the world. However, world pharmaceutical production and consumption is still unevenly dispersed around the world with the developed countries as the leading producers and consumers of pharmaceuticals. IMS Health (2010) stated that world pharmaceutical market was valued at US$ 875 billion with a growth rate of 4.1% over the previous year at the constant exchange rate. The volume of pharmaceutical industry has surged from USD 647 billion in 2005 to USD 875 billion in 2010, corresponding to an increase of 35.2%. During this period, the industry’s growth rate has witnessed a declining trend from 7.2% in 2005 to 4.1% in 2010. This decline is mainly associated with the slowdown in economic activity, especially in the developed countries which consume a large quantity of global pharmaceutical products. In 2008, economic slowdown in developed countries culminated into one of the worst global financial and economic crisis since the Great Depression. The negative effects were felt across the globe and the pharmaceutical sector experienced the same situation. However, in 2009, the negative effects of the crisis subsided and global economy has started to recover. Both in terms of production and consumption, global pharmaceutical market is highly concentrated in the developed regions like North America (38%), Europe (29%) and Japan (12%) which in 2010 accounted for nearly 80% of global market. Developing regions like Asia, Africa, Australia and Latin America with a share of nearly 85% of world population are accounted for only 21% of global pharmaceutical consumption in 2010 (Figure 11). A breakdown of pharmaceutical market in developing world reveals that Asia, Australia and Africa represent nearly 15% whereas Latin America accounts for 6% of the global pharmaceutical market.